Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • herstein
    Junior Member
    • Oct 2011
    • 4

    #1

    Cufflinks 0 FPKM values

    Hi,

    We are running tophat/cufflinks on 3 identical human rna samples which were sequenced in 3 different lanes on 2 different flowcells. All 3 samples are from the exact same library.

    When running cufflinks, the genes.fpkm_tracking file for one sample is showing some genes with 0 FPKM and status FAIL, however these same genes in the other two samples are showing a non-zero FPKM.

    We are using tophat-1.4.0, bowtie-0.12.7, and cufflinks-1.3.0

    We ran tophat with the -G option and provided the gtf file. We ran cufflinks with -G option providing the same gtf file that we gave to tophat. We also ran cufflinks with -u -N --compatible-hits-norm -b hg19_ucsc.fa

    We've tried running without options -N and --compatible-hits-norm but still had the same results.

    We are confused how with 3 identical samples, one shows up with 0 FPKM but the other two seem to have valid FPKM's. For the 0-FPKM gene, we checked the bam file in IGV and it is definitely mapped.

    Has anyone encountered a similar problem or does anyone have any insight into this?

    Thanks!
    --Jennifer
  • letusgo
    Member
    • Aug 2011
    • 17

    #2
    Hi,
    Have you solved this problem yet? I met the same problem now.

    Comment

    • jp.
      Senior Member
      • Jul 2013
      • 142

      #3
      I also have same problem. I got only few genes with 0 FPKM value.
      I mean, control vs treated; control has 0 FPKM but treated shows 1098.13 FPKM.
      Theoretically speaking, it has very high fold increase, but cuffdiff Inf ?????
      do I have to include it or exclude. I think, this is very significant expression ????
      Can you all tell me please ?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...